Tung et al. also reported that there is a kind of loop in which PDL1 overexpression increases YAP transcriptional activity and levels along with YAP-induced TKI drug resistance in NSCLC [23]. The gene discussed is YAP1; the disease is non-small cell lung carcinoma.